Edwards Lifesciences (NYSE:EW) said today it acquired mitral valve repair developer Harpoon Medical for $100 million in cash, with the potential for an additional $150 million in milestone payments over 10 years. Harpoon is developing a system designed to enable echo-guided repair of mitral valve regurgitation through the stabilization of prolapse leaflets to restore coaptation and […]
Baxter (NYSE:BAX) announced earlier this month it tapped former Medtronic (NYSE:MDT) senior VP of medicine and tech Stephen Oesterle for its board of directors, bringing the total seats on the board to 12. Oesterle moved to the venture capital firm New Enterprise Associates last Sept from his position at Medtronic. Before moving to NEA, Oesterle served […]
Edwards Lifesciences (NYSE:EW) took out a stake with an exclusive option to buy in Harpoon Medical potentially adding a mitral repair device to the mitral valve replacement being developed by recent acquisition CardiAQ Valve Technologies. Irvine, Calif.-based Edwards did not reveal the size of its stake in Harpoon when it released new guidance earlier this week. Harpoon, based […]
Harpoon Medical said it launched an early feasibility study of its minimally invasive mitral valve repair device, with aims to use the study to support CE Mark approval in the European Union. The Baltimore, Md.-based company is developing a device to “transform the treatment of mitral regurgitation,” by eliminating the need perform an invasive breastbone […]
Harpoon Medical is looking to move from concept to the clinic with the $3.8 million it raised in its Series A funding round in support of its mitral repair devices.